Effect of Progressive Exercise on Renal Transplant Patients
Primary Purpose
Renal Transplant, Fatigue, Vital Signs
Status
Recruiting
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Progressive relaxation exercise
Sponsored by
About this trial
This is an interventional supportive care trial for Renal Transplant
Eligibility Criteria
Inclusion Criteria: Patients underwent renal transplant within one year from the beginning of the study Patients having no communication problems Patients having a smart phone either own or o family member Exclusion Criteria: Patients having musculoskeletal, cardiopulmonary, or psychiatric disorders
Sites / Locations
- Baskent University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
exercise
Control
Arm Description
Participants will receive a training about progressive relaxation exercises on the first day, then given an audio-record containing instructions about exercises. They will perform exercises at home for 4 week and revisited by the principal investigator at the 2nd and 4th week.
Participants will receive routine care.
Outcomes
Primary Outcome Measures
Systolic and diastolic blood pressure
Maintaining or normalizing systolic and blood pressure within normal range (systolic: 90-140 mmHg; diastolic 60-90 mmHg)
fatigue level
Fatigue Severity Scale is a valid and 7-point Likert type scale. Possible scores range from 9-63. Higher scores indicate high level of fatigue. A score of 36 points or over indicates severe fatigue (Change= Lower score from the scale at the end of intervention compared to baseline).
Heart rate
Maintaining or normalizing heart rate within normal range (60 to 100 bpm)
Respiratory rate
Maintaining or normalizing respiratory rate within normal range (12-20 breath per minute)
Body temperature
Maintaining or normalizing body temperature within normal range (36-37 C° in tympanic measurement)
Oxygen saturation
Maintaining or normalizing oxygen saturation within normal range (between 95%-100% by pulse oximetry)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05876507
Brief Title
Effect of Progressive Exercise on Renal Transplant Patients
Official Title
The Effects of Progressive Exercises on the Vital Signs and Fatigue in Patients With Renal Transplant
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 13, 2023 (Actual)
Primary Completion Date
May 15, 2023 (Anticipated)
Study Completion Date
June 15, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Baskent University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of this interventional study is to determine the effect of progressive relaxation exercises on the vital signs and fatigue levels of patients with renal transplantation.
Detailed Description
Renal transplant patients experience intense level of fatigue as well as vital sign problems due to treatment protocol. This research is designed to determine the effect of progressive relaxation exercises on vital signs and fatigue level of patients with renal transplantation.
In this study, the participants will be randomized in a single blind manner (participant) to either intervention (4 week exercise program) or control (routine care) groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Transplant, Fatigue, Vital Signs, Progressive Relaxation Exercise, Nursing
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a single blind, randomized controlled study. The intervention group will receive an audio record explaining progressive relaxation exercise. Then participants will undergo training about the exercises. After training, the intervention group will perform the exercises at home by their own. The exercises will be performed everyday for 4 weeks about 25-30 minutes. Principal investigator will check the participants weekly about implementation of exercises.
Masking
ParticipantOutcomes Assessor
Masking Description
Double (Participant, Outcomes Assessor)
Allocation
Randomized
Enrollment
52 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
exercise
Arm Type
Experimental
Arm Description
Participants will receive a training about progressive relaxation exercises on the first day, then given an audio-record containing instructions about exercises. They will perform exercises at home for 4 week and revisited by the principal investigator at the 2nd and 4th week.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Participants will receive routine care.
Intervention Type
Behavioral
Intervention Name(s)
Progressive relaxation exercise
Intervention Description
Progressive relaxation exercises will take 25-30 minutes of patients daily.
Primary Outcome Measure Information:
Title
Systolic and diastolic blood pressure
Description
Maintaining or normalizing systolic and blood pressure within normal range (systolic: 90-140 mmHg; diastolic 60-90 mmHg)
Time Frame
Change fron baseline at 4th week
Title
fatigue level
Description
Fatigue Severity Scale is a valid and 7-point Likert type scale. Possible scores range from 9-63. Higher scores indicate high level of fatigue. A score of 36 points or over indicates severe fatigue (Change= Lower score from the scale at the end of intervention compared to baseline).
Time Frame
Change from baseline at 4th week
Title
Heart rate
Description
Maintaining or normalizing heart rate within normal range (60 to 100 bpm)
Time Frame
Change from baseline at 4th week
Title
Respiratory rate
Description
Maintaining or normalizing respiratory rate within normal range (12-20 breath per minute)
Time Frame
Change from baseline at 4th week
Title
Body temperature
Description
Maintaining or normalizing body temperature within normal range (36-37 C° in tympanic measurement)
Time Frame
Change from baseline at 4th week
Title
Oxygen saturation
Description
Maintaining or normalizing oxygen saturation within normal range (between 95%-100% by pulse oximetry)
Time Frame
Change from baseline at 4th week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients underwent renal transplant within one year from the beginning of the study
Patients having no communication problems
Patients having a smart phone either own or o family member
Exclusion Criteria:
Patients having musculoskeletal, cardiopulmonary, or psychiatric disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Şeyda Uzun Yağız, RN
Phone
+905392791581
Email
seydauzun97@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Sevcan Avcı Işık, PhD, RN
Phone
+905433177016
Email
sevcanavci@baskent.edu.tr
Facility Information:
Facility Name
Baskent University Hospital
City
Ankara
State/Province
Çankaya
ZIP/Postal Code
06490
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Şeyda Uzun Yağız, RN
Phone
+905392791581
Email
seydauzun97@gmail.com
First Name & Middle Initial & Last Name & Degree
Sevcan Avcı Işık, PhD, RN
Phone
+905433177016
Email
sevcanavci@baskent.edu.tr
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
It is not yet known if there will be a plan to make IPD available. The researchers will decide later.
Learn more about this trial
Effect of Progressive Exercise on Renal Transplant Patients
We'll reach out to this number within 24 hrs